Company Filing History:
3 out of 50 
2 out of 12 
2 out of 2 
Years Active: 2014-2020
Title: Innovations by Inventor Shunji Ishiwata in Anticancer Technology
Introduction: Shunji Ishiwata is a notable inventor based in Higashiosaka, Japan, with a significant contribution to medical technology through his innovations. With a total of four patents to his name, Ishiwata has focused particularly on enhancing the safety and efficacy of anticancer treatments.
Latest Patents: Ishiwata's recent patents include a CT value controller and an anticancer agent degradation apparatus. The CT value controller is designed to improve the degradation treatment of anticancer agents by utilizing a sophisticated mechanism that factors in relative humidity and ozone concentration to calculate corrected CT value increments. This ensures that the termination of the degradation treatment is accurately determined by monitoring when the integrated CT value reaches the set threshold. Additionally, his patented anticancer agent degradation method and apparatus provides a method to protect medical professionals from potentially hazardous exposure to anticancer agents, particularly during drug preparation. By exploiting ozone-containing air that is humidified, the apparatus effectively degrades the risk of flyoff from the agent.
Career Highlights: Ishiwata has worked with notable institutions such as Kinki University and Gto LLC, where he utilized his expertise to push the boundaries of current medical practices. His patents address critical issues faced by professionals in the medical field, especially in oncology.
Collaborations: Throughout his career, Ishiwata has collaborated with esteemed coworkers, including Atsushi Taga and Shozo Nishida. These partnerships have likely contributed to the innovative advancements seen in his work, combining expertise from different fields to enhance therapeutic methodologies.
Conclusion: Shunji Ishiwata stands out as a pioneering inventor whose work has the potential to significantly improve safety and effectiveness in the handling of anticancer agents. His contributions not only reflect his ingenuity but also highlight the importance of innovation in the medical technology sphere.